Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Trials|December 18, 2012
A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion: rationale and design of the Primary Stenting of Occluded Native Coronary Arteries IV studyKoen Teeuwen, Tom Adriaenssens, Ben J L Van den Branden, et al.Journal of the American College of Cardiology|June 7, 2008
Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarctionAlexander Hirsch, Robin Nijveldt, Joost D E Haeck, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 8, 2019
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trialRobin P Kraak, Ruben Yannick G Tijssen, Ivo M van Dongen, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 23, 2018
Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCIRuben Yannick G Tijssen, Robin P Kraak, Sjoerd H Hofma, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 29, 2020
Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-studyLaura S M Kerkmeijer, Ruben Y G Tijssen, Sjoerd H Hofma, et al.The New England Journal of Medicine|April 13, 2017
Bioresorbable Scaffolds versus Metallic Stents in Routine PCIJoanna J Wykrzykowska, Robin P Kraak, Sjoerd H Hofma, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 6, 2021
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trialLaura S M Kerkmeijer, Mick P L Renkens, Ruben Y G Tijssen, et al.BMJ Open|July 22, 2020
Complex Large-Bore Radial percutaneous coronary intervention: rationale of the COLOR trial study protocolThomas A Meijers, Adel Aminian, Koen Teeuwen, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 6, 2025
Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trialMick P L Renkens, Maik J D Grundeken, Laura S M Kerkmeijer, et al.International Journal of Cardiology|September 13, 2019
A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trialLaura S M Kerkmeijer, Ruben Y G Tijssen, Sjoerd H Hofma, et al.Pageof 3